Familial hypercholesterolemia: the inherited high cholesterol that's underdiagnosed by design

Familial hypercholesterolemia is an inherited genetic condition that impairs the body's ability to clear LDL cholesterol from the bloodstream, producing significantly elevated LDL levels from childhood onward rather than the gradual, diet- and lifestyle-influenced rise typical of most high cholesterol. Left untreated, that lifelong elevated exposure translates into dramatically increased risk of early heart attack and cardiovascular disease, often showing up decades earlier than typical age-related coronary disease.

The diagnosis gap is structural rather than purely a testing-access problem: a single elevated cholesterol reading on a routine panel is common and usually attributed to diet or lifestyle, so the specific pattern that should raise suspicion for familial hypercholesterolemia — very high LDL from a young age, a family history of early heart attacks, or LDL levels disproportionate to diet and weight — often doesn't get flagged as distinct from ordinary high cholesterol in a routine visit.

Genetic testing confirms the diagnosis, and it matters practically beyond the individual patient: because it's inherited in a pattern where each child of an affected parent has a substantial chance of also carrying it, a confirmed diagnosis in one family member is a direct prompt to test first-degree relatives — a cascade testing approach that identifies affected relatives far more efficiently than waiting for each person to individually present with high cholesterol on a routine panel.

For anyone with a personal or family history of very high cholesterol at a young age, or heart attacks in family members under 55, raising familial hypercholesterolemia specifically with a physician — rather than assuming standard high-cholesterol counseling covers it — is worth doing directly, since the condition calls for more aggressive treatment and earlier intervention than typical age-related high cholesterol.